A rehabilitation program to increase balance and mobility in ataxia of Charlevoix-Saguenay: An exploratory study.
Isabelle Lessard, Viviane Masterman, Isabelle Côté...
https://pubmed.ncbi.nlm.nih.gov/36576926/Actively Recruiting
Led by Laval University · Updated on 2026-02-18
84
Participants Needed
5
Research Sites
47 weeks
Total Duration
Spastic ataxias, including Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay and Spastic Paraplegia 7, cause walking difficulties and balance problems that increase the risk of falls. Currently, there are no drug treatments available for these diseases, and non-drug therapies have seen limited development despite their impact on patients lives and the high societal cost of falls. This research aims to evaluate a 12-week supervised rehabilitation program designed specifically for people with spastic ataxias and to explore its effects on disease severity, implementation in clinical settings, and cost-benefits. Participants will be randomly assigned to one of two groups. The intervention group will follow a 12-week rehabilitation program with three 60-minute sessions each week, including two therapy room sessions and one aquatherapy session in an adapted pool. Exercises focus on postural control, balance, coordination, and functional mobility, with difficulty tailored by physiotherapists. The control group will continue their usual care and activities without changes. The program is supervised by physiotherapists and physiotherapy technologists in small groups to ensure safety. Throughout the 64-week study, participants will undergo various assessments including measures of ataxia severity, walking speed, balance, physical activities, muscle tone, fatigue, quality of life, and more. Biological samples such as plasma, DNA, serum, RNA, urine, and saliva will be collected. Researchers will also evaluate patient impressions of change and group feedback. This comprehensive approach will help determine the rehabilitation programs impact and gather data on long-term outcomes and safety.
CONDITIONS
Effects of a Supervised Rehabilitation Program on Disease Severity in Spastic Ataxias
E
Elise Duchesne, Ph D.
A
Andrée Hardy
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Laval University
Lead Sponsor
McGill University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants in the intervention group engage in a 12-week supervised rehabilitation program consisting of three 60-minute training sessions per week, including two sessions in a therapy room and one session in an adapted pool. Participants in the control group continue their usual care and activities.
3 sessions per week (two therapy room sessions and one aquatherapy session) for a total of 36 sessions
Duration - Up to 64 weeks
Participants are followed for up to 64 weeks to assess disease severity, physical function, quality of life, and other health outcomes.
Assessments at baseline and at 64 weeks, plus community mobility monitored over two 7-day periods
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Isabelle Lessard, Viviane Masterman, Isabelle Côté...
https://pubmed.ncbi.nlm.nih.gov/36576926/Laval University
Lead Sponsor
McGill University
Collaborating Sponsor